GW Pharmaceuticals PLC Holding(s) in Company (5683P)
November 18 2016 - 4:31AM
UK Regulatory
TIDMGWP
RNS Number : 5683P
GW Pharmaceuticals PLC
18 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
---------------------------------------------------------------------------------------------------
1. Identity of the issuer or GW Pharmaceuticals PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- ------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
---------------------------------------------------------------- ---------------------------------
An acquisition or disposal of qualifying financial X
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------- ---------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------- ---------------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------- ---------------------------------
Other (please
specify):
--------------------------------------------------------- ----- ---------------------------------
3. Full name of person(s) The Goldman Sachs Group, Inc.
subject to the
notification obligation:
(iii)
----------------------------------------------------------- --------------------------------------
4. Full name of shareholder(s) Goldman Sachs International
(if different from 3.):(iv) Goldman, Sachs & Co.
Goldman Sachs Asset Management,
L.P.
----------------------------------------------------------- --------------------------------------
5. Date of the transaction 14 November 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- --------------------------------------
6. Date on which issuer 16 November 2016
notified:
----------------------------------------------------------- --------------------------------------
7. Threshold(s) that is/are Above 3%
crossed or
reached: (vi, vii)
----------------------------------------------------------- --------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
----------------- --------------------------------- --------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
----------------- --------------- ---------------- ----------- ------------------------ -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
----------------- -------------- --------------- ----------- --------- ------------- -------- -------------
Below Below
GB0030544687 3% 3% 94,532 0.03%
--------------- ---------------- ----------- --------- ------------- -------- -------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ --------------- ----------------------------- ----------------------- -----------------------
Stock Loan
(Physical) Open 4,171,947 1.38%
------------------ --------------- ----------------------------- ----------------------- -----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
(xv, xvi)
----------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of % of voting
financial price date Conversion voting rights (xix,
instrument period rights xx)
instrument
refers to
------------- ---------- ------------- ------------- ------------ -----------------
Nominal Delta
------------- ---------- ------------- ------------- ------------ -------- -------
CFD (Cash) 26-Mar-2026 1,259,580 0.42%
------------------------- ---------------------------- ------------ -------- -------
CFD (Cash) 19-Mar-2026 471,048 0.16%
------------------------- ---------------------------- ------------ -------- -------
CFD (Cash) 8-Oct-2026 87,600 0.03%
------------------------- ---------------------------- ------------ -------- -------
CFD (Cash) 8-Oct-2026 77,988 0.03%
------------------------- ---------------------------- ------------ -------- -------
CFD (Cash) 8-Oct-2026 51,780 0.02%
------------------------- ---------------------------- ------------ -------- -------
CFD (Cash) 29-May-2026 8,076 0.003%
------------------------- ---------------------------- ------------ -------- -------
Call Option
(Physical) 20-Jan-2017 2,100,000 0.69%
------------------------- ---------------------------- ------------ -------- -------
Call Option
(Physical) 18-Nov-2016 1,080,000 0.36%
------------------------- ---------------------------- ------------ -------- -------
--------------------------------------------------------------------------------------------------------------------
Total (A+B+C)
--------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------------- -------------------------------------------------------------
9,402,551 3.11%
----------------------------------------------------- -------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------------------
-----------------The Goldman Sachs Group, Inc.; 9,402,551
shares; 3.11%
Goldman Sachs (UK) L.L.C. (Controlled by The Goldman
Sachs Group, Inc.)
Goldman Sachs Group UK Limited (Controlled by Goldman
Sachs (UK) L.L.C.)
Goldman Sachs International (Controlled by Goldman Sachs
Group UK Limited)
The Goldman, Sachs & Co. L.L.C. (Controlled by The Goldman
Sachs Group, Inc.) 9,252,779 shares; 3.06%
Goldman, Sachs & Co. (Controlled by The Goldman, Sachs
& Co. L.L.C.) 9,252,779 shares; 3.06%
GSAM Holdings LLC (Controlled by The Goldman Sachs Group,
Inc.)
Goldman Sachs Asset Management, L.P. (Controlled by GSAM
Holdings LLC)
Proxy Voting:
-----------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
-------------------------------------------------------- -------------------------------
11. Number of voting rights proxy N/A
holder will cease to hold:
-------------------------------------------------------- -------------------------------
12. Date on which proxy holder will N/A
cease to hold voting rights:
-------------------------------------------------------- -------------------------------
General email contact:
13. Additional information: shareholderdisclosures@gs.com
-------------------------------------------------------- -------------------------------
14. Contact name: Joanna Foley
-------------------------------------------------------- -------------------------------
15. Contact telephone number: +44 207 051 9996
-------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEANFPFAPKFEF
(END) Dow Jones Newswires
November 18, 2016 04:31 ET (09:31 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Dec 2023 to Dec 2024
